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Abstract
Background: Chronic edema is a condition that is biologically complex, distressing for patients and socio-
politically weak. Like many other complex and chronic conditions, it has a low status within health care. The
result is that it has a low priority in health policy and consequently is undervalued and undertreated. While
evidence-based practice promotes a hierarchy of evidence, it is also the case that clinical practice is influenced
by a hierarchy of social status. These are as much political as they are scientific.
Methods and Results: This article will provide an explanation for why chronic edema is a low priority. It
will do this through a critical review of the literature. We examine this through the theoretical lens of Pierre
Bourdieu. The sociology of Bourdieu frames an understanding of power relations through habitus, field, and
capital. We will employ these theoretical tools to understand the way that chronic edema is situated within
the policy arena. We identify a number of social mechanisms that affect the status of chronic edema,
including diagnostic uncertainty, social capital, scientific capital, cultural capital and economic capital.
Conclusion: We argue that a whole system approach to care, based on human need rather than unequal power
relations, is a prerequisite for the delivery of good health care. The specialty of chronic edema is not a
powerless group and we identify some of the ways that the social mechanism that acts as barriers to change, can
also be employed to challenge them.
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Introduction
Health care systems confront many pressures. Thesepressures significantly affect the type of care delivered to
patients. While the basic principles of health care are to max-
imize health and minimize illness, the application of policy
takes place in complex contexts. An approach based on social
justice would endeavor to deliver services based on fairness and
human need. However, decisions about the provision of care is
affected by a variety of social, economic, cultural, and political
factors.1 Any analysis of policy needs to engage with these
different sociopolitical factors so that evidence-based policy
can be applied based, not only on identified needs, but also an
approach that recognizes the broader context. In this article, we
will explore this context as it effects chronic edema, which is
underrecognized and undertreated.2,3
We will approach this through the theoretical lens of the
sociologist Pierre Bourdieu. Bourdieu identified funda-
mental aspects to the social world, habitus, capital, and
field.4–6 Habitus is about how social behavior is embedded
in social action. Behavior is therefore a set of dispositions
that are durable, often regulated that are not straightfor-
wardly consciously enacted, but internalized and embodied
in human praxis. Habitus is not simply rule following, but a
disposition to adapt one’s actions to the social fields one
inhabits.
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Fields are socially structured spaces that incorporate prac-
tice rules. The field creates regulatory practices and shapes the
positions people occupy within an institution, an organization,
and can be potentially referred to as a set of objectively defined
social locations. Ones position within it are products of past
actions and the field and are a focus of continuous struggle and
conflict between different groups both within a field and
alongside other models of health care and the inherent tension
these engender. So, for the purposes of this article, we are
interested in the field of health care within which there are
subfields of medicine and allied health professionals and
within that further specialties with their own agendas. The
picture is complex with a frequent divide between private and
public health care systems. Attempting to promote a particular
part of the field (e.g., chronic edema) entails a struggle for
influence within the broader field of health care and this is not
simply a polite discussion and dialog based on rationally
generated evidence-based knowledge, but a competitive en-
gagement with deeply embedded social structures.
This engagement with the field involves the use of power.
Power is utilized through the third component of Bourdieu’s
theory of capital. Capital is not simply economic, but also
symbolic. There are multiple types of capital but the central
idea of capital is that people and groups access capital to
different degrees that enable them to have influence and
power within a field of practice. So academic credentials
provide a person more power in an educational field.
Throughout this article we will be referring to different types
of capital, including scientific, social, cultural, and economic
capital as ways that chronic edema is marginalized within the
health care field.
We should note that while we have identified these three
concepts of habitus, field, and capital as discrete ideas,
Bourdieu used these ideas as inextricably linked in the real
world. It has been noted for example that, in the health care
literature, the idea of capital has been emphasized at the ex-
pense of field, which potentially results in a culturalist ex-
planation. The consequence is an insufficient account of the
way that capital is only useful if it is situated within a broader
structuralist paradigm.7,8 However, field provides a key com-
ponent of an explanation for health service delivery that is
focused on the way that existing structures of domination of
the social relations that exist within that field and how the field
have been formed and could potentially be changed by the
social forces within that field. Within this article, we will in-
tegrate these ideas as an explanatory means to understand the
undervalued nature of chronic edema in the health care field.
The Problem of Diagnosis
Diagnosis is a process whereby disease is distinguished
from health, which should then lead to an appropriate treat-
ment.9 Problems may arise when there is uncertainty about
how to define symptoms. But from a sociological perspective,
diagnosis is also a social process in which medicine identifies
what is significant in the diagnostic process.10 In short, di-
agnosis frames the experience of illness, providing it with a
label and decides which experiences of illness are privileged
and which are silenced.11 Therefore, diagnosis is not just a
matter of biological dysfunction but exists in a social and po-
litical context. Furthermore, the application of a diagnosis
transforms the individual’s sense of himself or herself as they
generate a new narrative based on this label. While sociologists
have been concerned to broaden the scope of diagnosis, incor-
porating lay experiences into a relational approach to managing
illness; clinicians focus and appreciate the value of a precise
definition. This can be seen clearly in a debate in the Journal of
Lymphedema.12 This discussion was concerned to identify
whether the term lymphedema or chronic edema should be used.
The complexity of this discussion is not our concern within
this article, but what these clinicians were concerned about
was the policy implications of the two terms. While there
seemed to be a general preference for the term chronic ede-
ma, there was also anxiety that this would be confusing for
managers providing the service who are familiar with the
term lymphedema but not chronic edema. Perhaps they could
be used synonymously despite the different diagnostic and
treatment regimens associated with the different definitions?
Would a change in name affect funding and service provi-
sion? The authors are clearly concerned here with the ten-
sion between diagnostic accuracy and the profile of the
condition, which they are professionally engaged with. The
language of diagnosis clearly matters in relation to both
treatment and the profile of the disease and the existence of
this debate clearly illustrates the ongoing problems in pro-
viding a clear focus in the policy arena.
The issue of diagnosis is a profoundly complex issue
within the field of chronic edema and lymphedema. The
debate rages over whether chronic edema and lymphede-
ma are purely a set of symptoms or whether they constitute
a newly emerging health care problem. This is deeply
embedded in the newly emerging physiological data that
challenges long-held beliefs about the function of the ve-
nous and lymphatic circulation and is deeply engaging
academics in this field. However, this debate is not influ-
encing clinicians who work in nonspecialist areas of
practice.
The heterogeneous nature of the patients affected leads to a
lack of ownership of the problem. In some situations, such as
following cancer treatment, lymphedema may be perceived
by clinicians as a minor irritation to a patient rather than
having a profound effect on people’s lives. Clinicians may
actively distance themselves from the implications of their
intervention rationalizing that treatment of the underlying
disorder is the only relevant factor.
The lack of clarity over the definitions used to define
chronic edema and lymphedema are leading to confusion
over the objectives of treatment and what constitutes an ef-
fective outcome. Clinical outcome measures, such as volume
change in a limb, have some legitimacy and understanding in
a specialist lymphedema audience. There is, however, no
agreement over the size of volume change required to be
effective or a link to issues, such as health-related quality of
life, function, and cost-effectiveness. The term ‘‘volume
change’’ is not understood in the wider audience of health
care, in particular reimbursement and health care agencies
responsible for provision of care.
The patient understanding of the relevance of volume
change as an outcome measure has received scant attention
and issues such fear of cellulitis and unpleasant symptoms are
likely to be of greater importance. The lack of a common
language that allows a comparison of chronic edema with
other chronic illnesses further reduces the potential for a high
social capital and influence on the health care systems.
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Cultural Capital and the Prestige of Diseases
Having a firm, clearly defined diagnosis and attaching that
to a specialist practice alongside a program of research, all
contribute to the status of a disease. Some diseases are ac-
knowledged to be low status and neglected. For example,
there is now an extensive literature on neglected tropical
diseases.13 Scientific capital directs researchers to those ar-
eas, where there is the greater prestige, those that are con-
sidered more important. As Bourdieu14 points out there is a
hierarchy of science entailing a struggle for funding that
generates a market approach to knowledge. The particular
position of a group within the field of health is dependent on
the historical crystallization or previous struggles and the
way that various forms of symbolic capital have become
embedded in the field. Chronic edema has struggled to gain
attention for a number of reasons.
There is good evidence that chronic edema is exten-
sive.2,15 However, this is not reflected in its profile as an
area of concern. But more fundamentally this lack of in-
terest reflects broader ideas about the prestige of diseases
and specialties. In short, some diseases have more prestige
than others do. In general, the acute conditions that respond
to invasive procedures, vital organs in the upper part of the
body have higher prestige than chronic conditions that af-
fect the lower body or nonspecific parts of the body.16,17
There is also evidence that medical students who are more
career oriented tend toward technique-oriented specialties
that reflect biomedical practices and are seen to have higher
prestige.18 Chronic edema is not mentioned in any of these
research articles, but given the chronic nature of the illness
and the treatment regimens that are primarily nurse related
and nonsurgical, it is reasonable to suggest that chronic
edema has low prestige or what Bourdieu would refer to as
cultural capital.
Scientific Capital
To examine science and scientific practice, sociologists
explore what social mechanisms are in place that orient sci-
ence to particular objects of knowledge and not others. Why
is it that some subjects have higher status than others and how
do they accumulate scientific capital.19 As we have already
argued, different medical specialties have higher prestige
than others and it is clear that chronic edema is a specialty
that struggles to gain attention. The efficacy of treatment
regimes is only partly a factor in this struggle for attention. So
for example, the efficacy and usefulness of genetic knowl-
edge continues to be modest, but has managed to attract high
levels of investment due to its status as ‘‘big science.’’20
Some have noted how attention for funding is rooted in what
they refer to as expectational capital21 in which researchers
are able to promote their area through promises of future
success that are based on inflated claims about the possibil-
ities of success rather than a realistic evaluation. However,
researchers are simply working within the paradigm of
funding streams and unlikely to access support if they do not
put an optimistic gloss on their projects. Working in the
field of chronic edema is unlikely to generate this kind of
interest, as it does not conform to an ideology of clear-cut
interventions.
Cultural Capital and Media Representations
The evolution of a specialty depends upon a variety of
factors, the type of condition, its scientific status, the orga-
nizational possibilities, the usefulness in meeting health care
and institutional priorities, the prestige associated with the
problem, and which social groups suffer from it. But there is
also a less tangible but nonetheless important cultural context
in which health care is delivered. The media is important in
the way that it represents health and health care systems.22 It
can even influence the development of a specialty. Emer-
gency care has a long history of being a medical backwa-
ter with a low status. The open-ended nature of its access
(so anyone can turn up), and its subsequent lack of focus on a
specific condition and its history as little more than an add on
to orthopedics has resulted in it being defined as a low pri-
ority.23 Many factors have influenced this change, not least it
focuses on the acute and traumatic, but part of this has been
its cultural representations, which have found their place in a
cultural context in which the emergency, the heroic, the
world weary, and the nonconformist individual operates in a
world that is anxious and fragile.24 The high profile of these
television programs, both fictional and documentary, has
contributed to profile of the specialty and is acknowledged by
leading figures in the specialty itself.24
Specific diseases are also promoted in ways that reflect a
strong cultural component. For example, Lyme disease has
had its profile substantially enhanced using celebrity sup-
port.25 Media depictions can also have negative effects. In an
analysis of the program, Seinfeld, negative and stigmatizing
representations of skin conditions were the norm and the
subject of satire, ridicule, and exaggeration.26 So, problems
of the skin are less likely to engender a sympathetic repre-
sentation. It lacks drama and feeds into a general cultural
discourse of disgust that is often internalized by patients.27
Economic and Social Capital
To examine the health care sector as a field is to understand
the competing nature of different actors within a social sys-
tem who employ different strategies to enhance the position
of their speciality.7 Chronic edema has problems asserting
itself as condition worthy of attention by policy makers.
Chronic conditions are often spatially spread through the
community rather than organized in a defined space within a
hospital. For example, surgical conditions generate teams
who focus on defined problems, whereas chronic edema is
often situated in the home and nursing homes, often unno-
ticed and undertreated.2
It is, however, possible to make an economic case for
chronic edema. If the idea of chronic edema is broadened,
then an argument can be made to support more attention.
There is literature that identifies the effects of living with
chronic edema. So, living with chronic edema generates
profound psychosocial consequences, including emotional
issues, body image, an undermining of self-confidence and a
sense of self, a feeling of being unattractive and disgusting,
depression, anxiety, and psychological distress. It can affect
sexuality, relationships, and social contacts, which can lead
to social isolation and a sense of abandonment from health
care system that provide minimal support.27 While these
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aspects should promote greater attention based on human
need, these issues tend to have low social capital and prestige
when faced with more clearly identified medical problems
with clear medical solutions.17
Furthermore, the costs of living with chronic edema is
dependent on service provision. Boyages et al.28 have
identified significant financial costs borne by Australian
women with lymphedema that is secondary to breast cancer
as they must pay for treatment products. Wagner et al.29
have identified significant problems associated with ac-
cessing insurance cover in Japan. Weiss30 has noted that in
the USA there are similar problems arguing that despite the
low cost of treatments, and the potential savings in pre-
vention with complications, such as cellulitis, insurance
companies have actively resisted any attempts to fund these
treatments. Identifying the costs of chronic edema is always
problematic but it is reasonable to include social factors in
any costing process. These might include the increasing
care burden on families, the increased levels of sickness,
loss of productivity, and quality-of-life issues such as
mental health services. Humphreys and Thomas31 argue
that there is ultimately a cost saving to be made if all these
factors can be considered. Gutknecht et al.32 support this by
incorporating direct and indirect costs into their analysis
and suggest that a comprehensive treatment program im-
proves care and also has the potential to decrease costs.
However, these articles are cautious about cost savings and
therefore have limitations in promoting and setting up such
programs of care in the competitive environment of health
care systems.
Conclusion and Implications
According to Bourdieu19 the obstacles to scientific prog-
ress are fundamentally social. Science is inevitably a part of
the political domain. However, it should progress in a way
that is not reducible to politics. The purpose of sociology is
not to relativize science but to situate it and then to under-
stand what social mechanisms are at work in defining the
practice of science. Bourdieu situates scientific knowledge
within a field, in which struggles take place for influence
based upon their position within that field and the amount of
capital that agents can employ within that struggle. Health
care is not just about science however, but is a clinical
practice employed on people and it is the purpose of health
care to deliver care that meets the needs of people. While the
idea of what a need is may be problematic to define, the
argument that these needs are not being met for people with
chronic edema is compelling. We have outlined some of the
key issues affecting this group (Fig. 1).
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